Sandoz Gets US Denosumab Approvals – But When Will They Launch?

FDA Also Grants Interchangeability Designation For First Biosimilars To Prolia And Xgeva

Two Blue And Black Badges Representing FDA Approvals
Sandoz has received two denosumab biosimilar approvals • Source: Shutterstock

More from Biosimilars

More from Products